Publication: An open-label trial to assess the safety of regorafenib in turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
No Thumbnail Available
Date
2015-06-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford University Press
Abstract
Bu çalışma, 1-4 Temmuz 2015 tarihlerinde Barcelona'da düzenlenen ESMO 17. Dünya Gastrointestinal Kanser Kongresinde bildiri olarak sunulmuştur.
Description
Keywords
Science & technology, Life sciences & biomedicine, Oncology, Oncology
Citation
Collections
Metrikler